Target intelligence / Profile preview

SCP2 sterol-binding domain-containing protein 1 (SCP2D1)

Target
SCP2D1
Molecular classification
Other (lipid-binding protein; not a receptor, enzyme, transporter, or classical target class)
01

Overview

SCP2 sterol-binding domain-containing protein 1 (SCP2D1) is a member of a family of lipid-binding proteins that contain the sterol carrier protein 2 (SCP2) domain. SCP2D1 is encoded by the SCP2D1 gene (formerly C20orf79, HSD22) and shows homology to classical SCP2 proteins, which bind and transfer cholesterol, fatty acids, and other lipids between intracellular membranes. It is primarily implicated in nonvesicular intracellular trafficking of cholesterol and other lipids, affecting lipid and cholesterol homeostasis and possibly contributing to certain metabolic or lipid-storage diseases. Unlike the canonical SCP2/SCpX proteins, SCP2D1's specific physiological and pathological roles are less well-characterized but may relate to diseases involving abnormal lipid handling, such as certain corneal dystrophies. SCP2D1 is classified structurally as a lipid-binding protein but is not an enzyme, receptor, transporter, or established therapeutic drug target at this time [1][2][3].

Other names
SCP2D1C20orf79HSD22dJ1068E13.2sterol carrier protein 2-like proteinSCP2 sterol binding domain containing 1
02

Biological functions

Intracellular lipid transportcholesterol traffickingfatty acid binding
03

Disease associations

Corneal dystrophy (posterior polymorphous 1)potentially involved in diseases involving abnormalities in lipid trafficking and metabolism

Beyond the preview

Go deeper on SCP2 sterol-binding domain-containing protein 1 (SCP2D1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SCP2 sterol-binding domain-containing protein 1 (SCP2D1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call